Chris Wasden, Twill's Chief Strategy Officer recently joined DTx Insider's Series for its first webinar. Episode one was set to cover
the current DTx
landscape and identify key challenges and opportunities for Pharma
in the adoption and development of digital therapeutics
for success. If couldn't make the live webinar you can watch the pre-recorded webinar here.
